Related Experiment Video
Updated: Jun 16, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Hypertrophic cardiomyopathy: practical steps for preventing sudden death
1Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, MN, 55407, USA. hcm.maron@mhif.org.
Insights
Hypertrophic cardiomyopathy (HCM) is a rare but fatal condition in athletes. Differentiating HCM from athlete's heart requires careful evaluation of specific cardiac and genetic markers.
Area of Science:
- Cardiology
- Sports Medicine
- Genetics
Background:
- Hypertrophic cardiomyopathy (HCM) is a rare cause of sudden cardiac death in young athletes.
- Distinguishing HCM from physiological cardiac hypertrophy (athlete's heart) presents a diagnostic challenge.
- HCM deaths in young, seemingly healthy individuals garner significant attention.
Purpose of the Study:
- To review the diagnostic approaches for differentiating hypertrophic cardiomyopathy (HCM) from athlete's heart.
- To highlight key clinical and genetic factors in the differential diagnosis of HCM.
- To provide recommendations for athletic participation in individuals diagnosed with HCM.
Main Methods:
- Review of clinical presentation, family history, and physical examination findings in HCM.
- Electrocardiography (ECG) and echocardiography as primary diagnostic tools.
- Discussion of genetic testing and its current role in HCM diagnosis.
Main Results:
- Differential diagnosis relies on identifying heterogeneous left ventricle hypertrophy, left atrial enlargement, and specific ECG patterns.
- Family history and gene mutations are crucial indicators for HCM.
- Molecular detection methods are not yet standard clinical practice.
Conclusions:
- Accurate differentiation between HCM and athlete's heart is critical for preventing sudden cardiac death.
- A combination of clinical, imaging, and genetic assessments aids in diagnosis.
- Athletes with confirmed HCM should avoid high-intensity competitive sports.
Abstract:
Hypertrophic cardiomyopathy (HCM) is a rare cause of death among the many participants in sports and recreational athletics, but it attracts widespread attention because the deaths occur in young, apparently healthy people. Differentiating HCM from conditioning hypertrophy (athlete's heart) remains a challenge. Routine detection of HCM patients is most commonly done with family history, physical examination, electrocardiography, and echocardiography. Keys to the differential diagnosis include evidence of heterogenous left ventricle hypertrophy, left atrial enlargement, unusual ECG patterns, and family history or gene mutations. Molecular detection methods for known defective genes in HCM have not yet become routine clinical tools. Athletes with unequivocal HCM should not participate in competitive sports, except for perhaps some low-intensity ones.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy VI: Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...

